PMC:7247521 / 27354-28994
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
391 | 1625-1628 | Disease | denotes | XCH | |
403 | 663-667 | Gene | denotes | OCT2 | Gene:6582 |
404 | 790-794 | Gene | denotes | hERG | Gene:2078 |
405 | 808-812 | Gene | denotes | hERG | Gene:2078 |
406 | 832-835 | Species | denotes | rat | Tax:10116 |
407 | 723-731 | Disease | denotes | toxicity | MESH:D064420 |
408 | 756-764 | Disease | denotes | toxicity | MESH:D064420 |
409 | 842-850 | Disease | denotes | toxicity | MESH:D064420 |
410 | 859-873 | Disease | denotes | hepatotoxicity | MESH:D056486 |
411 | 875-893 | Disease | denotes | skin sensitisation | MESH:D012871 |
412 | 906-914 | Disease | denotes | toxicity | MESH:D064420 |
413 | 127-133 | CellLine | denotes | Caco-2 | CVCL:0025 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T342 | 44-53 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T343 | 87-91 | UBERON:0000165 | denotes | oral |
T344 | 127-133 | CL_1 | denotes | Caco-2 |
T345 | 184-188 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T346 | 234-243 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T347 | 259-265 | UBERON:0000479 | denotes | tissue |
T348 | 279-285 | UBERON:0000479 | denotes | tissue |
T349 | 300-306 | UBERON:0001969 | denotes | plasma |
T350 | 388-403 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological |
T351 | 475-494 | UBERON:0000120 | denotes | blood-brain barrier |
T352 | 496-499 | UBERON:0000120 | denotes | BBB |
T353 | 505-527 | UBERON:0001017 | denotes | central nervous system |
T354 | 529-532 | UBERON:0001017 | denotes | CNS |
T355 | 551-560 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T356 | 578-583 | UBERON:0002113 | denotes | renal |
T357 | 627-632 | UBERON:0002113 | denotes | renal |
T358 | 633-647 | CHEBI:25697;CHEBI:25697;PR:000014988 | denotes | organic cation |
T359 | 648-661 | PR:000014988 | denotes | transporter 2 |
T360 | 663-667 | PR:000013036 | denotes | OCT2 |
T361 | 682-691 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T362 | 751-755 | CHEBI:34018;CHEBI:34018 | denotes | AMES |
T363 | 790-794 | PR:P11308 | denotes | hERG |
T364 | 797-806 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T365 | 808-812 | PR:P11308 | denotes | hERG |
T366 | 816-825 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T367 | 827-831 | UBERON:0000165 | denotes | oral |
T368 | 832-835 | NCBITaxon:10114 | denotes | rat |
T372 | 954-963 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T85 | 134-138 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T86 | 161-165 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
T87 | 259-265 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
T88 | 279-285 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
T89 | 300-306 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T90 | 475-480 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T91 | 481-486 | Body_part | denotes | brain | http://purl.org/sig/ont/fma/fma50801 |
T92 | 505-527 | Body_part | denotes | central nervous system | http://purl.org/sig/ont/fma/fma55675 |
T93 | 529-532 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
T94 | 875-879 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T24 | 161-165 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
T25 | 259-265 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T26 | 279-285 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
T27 | 475-494 | Body_part | denotes | blood-brain barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
T28 | 475-480 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T29 | 481-486 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955 |
T30 | 505-527 | Body_part | denotes | central nervous system | http://purl.obolibrary.org/obo/UBERON_0001017 |
T31 | 513-527 | Body_part | denotes | nervous system | http://purl.obolibrary.org/obo/UBERON_0001016 |
T32 | 529-532 | Body_part | denotes | CNS | http://purl.obolibrary.org/obo/UBERON_0001017 |
T33 | 875-879 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T215 | 75-76 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T216 | 127-138 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco-2 cell |
T217 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
T218 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
T219 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
T220 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
T221 | 161-165 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
T222 | 300-306 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T223 | 475-480 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T224 | 475-480 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T225 | 481-486 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
T226 | 481-486 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | brain |
T227 | 505-527 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | central nervous system |
T228 | 505-527 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | central nervous system |
T229 | 505-527 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | central nervous system |
T230 | 529-532 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
T231 | 529-532 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
T232 | 529-532 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | CNS |
T233 | 571-572 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T234 | 633-640 | http://purl.obolibrary.org/obo/OBI_0100026 | denotes | organic |
T235 | 633-640 | http://purl.obolibrary.org/obo/UBERON_0000468 | denotes | organic |
T236 | 875-879 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
T237 | 875-879 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
T238 | 875-879 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
T239 | 875-879 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
T240 | 875-879 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
T241 | 947-953 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T242 | 1079-1081 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
T243 | 1260-1262 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T244 | 1370-1373 | http://purl.obolibrary.org/obo/CLO_0007875 | denotes | MS1 |
T245 | 1370-1373 | http://purl.obolibrary.org/obo/CLO_0052410 | denotes | MS1 |
T246 | 1402-1404 | http://purl.obolibrary.org/obo/CLO_0009126 | denotes | SR |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T168 | 184-188 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T169 | 633-647 | Chemical | denotes | organic cation | http://purl.obolibrary.org/obo/CHEBI_25697 |
T170 | 641-647 | Chemical | denotes | cation | http://purl.obolibrary.org/obo/CHEBI_36916 |
T171 | 797-806 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T172 | 813-815 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T173 | 816-825 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T174 | 1052-1054 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
T176 | 1079-1081 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
T177 | 1115-1125 | Chemical | denotes | Medicarpin | http://purl.obolibrary.org/obo/CHEBI_6714 |
T178 | 1137-1147 | Chemical | denotes | Cianidanol | http://purl.obolibrary.org/obo/CHEBI_15600 |
T179 | 1207-1209 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
T180 | 1263-1272 | Chemical | denotes | letrozole | http://purl.obolibrary.org/obo/CHEBI_6413 |
T181 | 1349-1359 | Chemical | denotes | naringenin | http://purl.obolibrary.org/obo/CHEBI_50202 |
T182 | 1374-1387 | Chemical | denotes | Leucocyanidol | http://purl.obolibrary.org/obo/CHEBI_11412|http://purl.obolibrary.org/obo/CHEBI_15758 |
T184 | 1472-1475 | Chemical | denotes | Tyr | http://purl.obolibrary.org/obo/CHEBI_17895|http://purl.obolibrary.org/obo/CHEBI_18186|http://purl.obolibrary.org/obo/CHEBI_46858 |
T187 | 1478-1481 | Chemical | denotes | Phe | http://purl.obolibrary.org/obo/CHEBI_17295|http://purl.obolibrary.org/obo/CHEBI_29997 |
T189 | 1498-1512 | Chemical | denotes | Liquiritigenin | http://purl.obolibrary.org/obo/CHEBI_28777 |
T190 | 1531-1540 | Chemical | denotes | taxifolin | http://purl.obolibrary.org/obo/CHEBI_38747 |
T191 | 1593-1602 | Chemical | denotes | flavanone | http://purl.obolibrary.org/obo/CHEBI_5070 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T99 | 633-659 | http://purl.obolibrary.org/obo/GO_0015695 | denotes | organic cation transporter |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T196 | 0-179 | Sentence | denotes | Regarding the absorption parameters, all 20 compounds (Table 2 ) presented a promising oral availability including the optimal Caco-2 cell permeability, HIA and skin permeability. |
T197 | 180-411 | Sentence | denotes | The drug distribution results showed that most of the compounds distributed in tissue (VDss> 0.45: tissue, VDss <−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target. |
T198 | 412-534 | Sentence | denotes | Only compound W5 and W11 were entirely unable to penetrate the blood-brain barrier (BBB) and central nervous system (CNS). |
T199 | 535-669 | Sentence | denotes | In addition, 15 compounds presented a good renal elimination and were not substrates of the renal organic cation transporter 2 (OCT2). |
T200 | 670-925 | Sentence | denotes | Finally, 14 compounds did not present any particular toxicity problems including AMES toxicity, maximum tolerated dose, hERG I inhibitor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity (Fig. 7B). |
T201 | 926-974 | Sentence | denotes | Table 2 20 potential active compounds from QFPD. |
T202 | 975-1040 | Sentence | denotes | Pubchem Molecular Name Structure Pubchem Molecular Name Structure |
T203 | 1041-1101 | Sentence | denotes | CID6918970 M3 ZINC5356864 CID10019512 S5 3-O-Methylviolanone |
T204 | 1102-1147 | Sentence | denotes | CID336327 M5 Medicarpin CID9064 W5 Cianidanol |
T205 | 1148-1194 | Sentence | denotes | CID14057197 O1 – CID182232 W11 (+)-Epicatechin |
T206 | 1195-1251 | Sentence | denotes | CID42607889 O2 Alysifolinone CID25721350 X1 ZINC13130930 |
T207 | 1252-1309 | Sentence | denotes | CID3902 S1 letrozole CID14135323 X2 (2S)-dihydrobaicalein |
T208 | 1310-1359 | Sentence | denotes | CID821279 X4 ZINC338038 CID439246 MXO1 naringenin |
T209 | 1360-1419 | Sentence | denotes | CID440833 MS1 Leucocyanidol CID676152 SO1 SR-01,000,767,148 |
T210 | 1420-1482 | Sentence | denotes | CID177149 MX16 (+)-Vestitol CID11438306 SX1 cyclo(L-Tyr-l-Phe) |
T211 | 1483-1540 | Sentence | denotes | CID114829 MX17 Liquiritigenin CID712316 WO1 (-)-taxifolin |
T212 | 1541-1603 | Sentence | denotes | CID928837 MX8 ZINC519174 CID373261 XO1 Eriodyctiol (flavanone) |
T213 | 1604-1632 | Sentence | denotes | M: MXSG, S: SGMH, X: XCH, O: |
T214 | 1633-1640 | Sentence | denotes | Others. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T2 | 1523-1526 | GlycoEpitope | denotes | WO1 | http://www.glycoepitope.jp/epitopes/AN0690 |